Nevertheless, IDH mutations are linked to angiogenesis,[9] and it was reported that the activity of the angiogenesis module in a tumor was associated with the signal intensity of contrast enhancement.[40,41] Therefore, it is reasonable that the imaging features extracted from contrast-enhanced T1WIs can be applied to predict whether GBMs have IDH mutations. Here, IDH2 is linked to neoplasm.